Vivatides Therapeutics

Private

Woburn, MassachusettsHealthcare & Life Scienceshttps://vivatides.com/

Last Round

Series A

Apr 10, 2026

Total Funding Raised

$64M

Company Overview

Vivatides Therapeutics is a biotechnology company that develops extrahepatic RNA-targeting therapeutics using proprietary delivery technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticssiRNAantisense oligonucleotidesASOdrug delivery platformextrahepatic deliveryoligonucleotide therapyligand conjugationgene expression modulationgene silencingbiotech licensingRNA medicinedrug discoverytherapeutic pipelinepreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivatides Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Vivatides Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vivatides Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 10, 2026
Seed	Aug 20, 2025

View all Funding Rounds

Vivatides Therapeutics Investors

Notable investors and investment history

Vivatides Therapeutics investors
Investor	Rounds
HighLight Capital	Series A
TF Capital	Series A
Qiming Venture Partners	Seed, Series A
Apricot Capital	Series A, Seed

View all Investors

Vivatides Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Vivatides Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vivatides Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts

Year Founded2025

Last FundingApr 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.